CD163 and neoplasm: Further phenotypic characterization of stabilin-1 positive cells using monocyte/macrophage marker CD163 revealed that CD68+Stab-1+ TAM co-expressed CD163 in certain tumor areas whereas CD68−Stab-1+ cells were typically negative for CD163 (Figure 2E and Supplementary Figure 3).